Zynex announces 247% order growth and increases q2 adjusted ebitda estimate

Englewood, colo., july 15, 2021 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased adjusted ebitda estimate for q2 2021.

ZYXI Ratings Summary

ZYXI Quant Ranking